Danuta Galicka-Latała
About
In The Last Decade
Danuta Galicka-Latała
31 papers receiving 288 citations
Peers
Comparison fields: 5 of 58
- Cardiology and Cardiovascular Medicine 120
- Endocrinology, Diabetes and Metabolism 95
- Surgery 90
- Genetics 37
- Molecular Biology 36
Countries citing papers authored by Danuta Galicka-Latała
This map shows the geographic impact of Danuta Galicka-Latała's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Danuta Galicka-Latała with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Danuta Galicka-Latała more than expected).
Fields of papers citing papers by Danuta Galicka-Latała
This network shows the impact of papers produced by Danuta Galicka-Latała. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Danuta Galicka-Latała. The network helps show where Danuta Galicka-Latała may publish in the future.
Co-authorship network of co-authors of Danuta Galicka-Latała
This figure shows the co-authorship network connecting the top 25 collaborators of Danuta Galicka-Latała. A scholar is included among the top collaborators of Danuta Galicka-Latała based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Danuta Galicka-Latała. Danuta Galicka-Latała is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 51 | |
| 2 | 11 | |
| 3 | 30 | |
| 4 | 25 | |
| 5 | [Markers of metabolic syndrome and peptides regulating metabolism in survivors of childhood acute lymphoblastic leukemia]. | 2 |
| 6 | [Heart rate variability in type 1 diabetic patients with retinopathy. Part I. Frequency analysis]. | 1 |
| 7 | [Underfoot pressure distribution of female patients with obesity and plantar fasciitis]. | 6 |
| 8 | 16 | |
| 9 | [Frequency of celiac disease and irritable bowel syndrome coexistance and its influence on the disease course]. | 11 |
| 10 | [The role of celiac disease and type 1 diabetes coexistance. Is celiac disease responsible for diabetic status?]. | 2 |
| 11 | [Coeliac disease and other autoimmunological disorders coexistance]. | 3 |
| 12 | [Diagnostic value of serum amyloid A protein (SAA) determination]. | 1 |
| 13 | 30 | |
| 14 | 62 | |
| 15 | [Role of neopterin in clinical diagnostics]. | 1 |
| 16 | [Diagnostic value of procalcitonin (PCT) determination]. | 2 |
| 17 | 2 | |
| 18 | [Predictors for diabetic neuropathy according to applied criteria of its diagnosis]. | 4 |
| 19 | [Uprighting test, deep respiration test and Valsalva test in patients with diabetes type 1]. | 0 |
| 20 | [Reactive gastritis in patients with diabetics with dyspeptic symptoms]. | 3 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.